Polyglucosan storage disease in a dog resembling Lafora's disease

Journal of Veterinary Internal Medicine

Volumn 16, Issue 2, 2002, Pages 201-207

  Schoeman, Tanya ^a   Williams, June ^a   Van Wilpe, Erna ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAN; GLYCOGEN; POLYGLUCOSAN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; CASE REPORT; CELL INCLUSION; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; FEMALE; ISOLATION AND PURIFICATION; METABOLISM; MUSCLE; MYOCLONUS EPILEPSY; PATHOLOGY; PROGNOSIS; ULTRASTRUCTURE;

ANIMALS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; FEMALE; GLUCANS; GLYCOGEN; INCLUSION BODIES; LAFORA DISEASE; MUSCLES; PROGNOSIS;

EID: 0036515932     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb02356.x     Document Type: Article

References (31)

1. Elliot EJ, Talbot IC, Pye IF, et al. Lafora disease: A progressive myoclonus epilepsy. J Paediatr Child Health 1992;28:455-458
2. Iannaccone S, Zucconi M, Quattrini A, et al. Early detection of skin and muscular involvement in Lafora disease. J Neurol 1991;238: 217-220.
3. Karimipour D, Lowe L, Blaivas M, et al Lafora disease: Diagnosis by skin biopsy J Am Acad Dermatol 1999;41:790-792.
4. Schwarz GA, Yanoff M. Lafora's disease, distinct clinico-pathologic form of Unverricht's syndrome. Arch Neurol 1965;12:172-188.
5. Minassian BA, Lee JR, Herbrick IA, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy Nat Genet 1998;2:171-174.
6. Ganesh S, Agarwala KL, Ueda K, et al Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes Hum Mol Genet 2000:9: 2251-2261.
7. Cusick PK, Cameron AM, Parker AJ. Canine neuronal glycoproteinosis - Lafora's disease in the dog. J Am Anim Hosp Assoc 1976;12:518-521.
8. Holland JM, Davis WC, Prieur DJ, Collins GH. Lafora's disease in the dog. A comparative study. Am J Pathol 1970;58;509-530.
9. Jian Z, Alley MR, Cayzer J, Swinney GR. Lafora's disease in an epileptic Basset hound. N Z Vet J 1990;38:75-79.
10. Kaiser E. Krauser K, Schwartz-Porsche D. Lafora's disease (progressive myoclonus epilepsy) in the Basset Hound - Early diagnosis by muscle biopsy. Tierärztliche Praxis 1991;19:290-295.
11. Whitenack DL. Neuronal glycoproteinosis (Lafora's disease) in the dog. American Association of Veterinary Laboratory Diagnosticians. 21st Annual Proceedings, Madison, WI, 1978;493-496.
12. Davis KE, Finnie JW, Hooper PT. Lafora's disease in a dog. Aust Vet J 1990;67:192-193.
13. Tomchick TL. Familial Lafora's disease in the beagle dog. Fed Proc 1973;32:821.
14. Hegreberg GA, Padgett GA. Inherited progressive epilepsy of the dog with comparisons to Lafora's disease of man. Fed Proc 1976; 35:1202-1205.
15. Hall DG, Steffens WL, Lassiter L. Lafora bodies associated with neurologic signs in a cat. Vet Pathol 1998;35:218-220.
16. Fitzmaurice SN, Rusbridge C, Shelton GD, et al. Familial myoclonic epilepsy in the miniature wirehaired dachshund. J Vet Intern Med 2001;15:72-73 (ESVN abstract).
17. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1998;28:411-448.
18. Pearse AGE. Histochemistry Theoretical and Applied, 4th ed. Edinburgh. Churchill Livingstone, 1985:655-833.
19. Bancroft JD, Stevens A. Theory and Practice of Histological Techniques. Edinburgh: Churchill Livingstone; 1977:131-147.
20. Grocott RG A stain for fungi in tissue sections and smears using Gomori methenamine silver nitrate technique. Am J Clin Pathol 1955;25:975-979.
21. Prophet EB, Mills B. Arrington JB, Sobin LH. Armed Forces Institute of Pathology: Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992:162-163.
22. Mallory FB. Pathological Technique. New York, NY: Hafner Publishing Company; 1961.275.
23. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. A Text and Atlas of Physiological and Pathological Alterations in the Fine Structure of Cellular and Extracellular Components, 4th ed. London: Butterworths, 1994 970-973.
24. Coleman DL, Gambetti P, Mauro SD, Blume RE. Muscle in Lafora disease. Arch Neurol 1974;31:396-406.
25. Samlaska CP, McBurney J, Sau P. James WD. Lafora's disease: What is the best site for skin biopsy? J Am Acad Dermatol 1989;21: 791-792.
26. Cavanagh JB. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Rev 1999;29:265-295.
27. Moses SW. Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediatr Gastroenterol Nutr 1990;11:55-174.
28. Fyfe JC, Giger U, Van Winkle TJ, et al. Glycogen storage disease type IV: Inherited deficiency of branching enzyme activity in cats. Pediatr Res 1992;32:719-725.
29. Engel AG, Franzini-Armstrong C, Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C, ed. Myology - Basic and Clinical, 2nd ed. New York, NY: McGraw-Hill; 1994:1565-1566.
30. Carmichael KP. Diagnostic features of polysaccharide storage myopathy. Compend Cont Educ 2000;5:507-509.
31. Harvey JW, Giger U. Animal models of human disease; Muscle-type phosphofructokinase deficiency (glycogen storage disease type VII). Comp Pathol Bull 1991;23:3-4.